Cargando…
TnP Peptide Suppresses Experimental Autoimmune Encephalomyelitis (EAE) in a Preclinical Mouse Model
TnP is a family of patented synthetic peptides which is in a preclinical development stage with valuable potential therapeutic indication for multiple sclerosis (MS), an autoimmune demyelinating disease of the central nervous system (CNS). The use of a preclinical animal model, such as experimental...
Autores principales: | Lima, Carla, Maleski, Adolfo Luis Almeida, Bernardo, Jefferson Thiago Gonçalves, Zelli, Vitor Cataldi, Komegae, Evilin Naname, Lopes-Ferreira, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988151/ https://www.ncbi.nlm.nih.gov/pubmed/35401524 http://dx.doi.org/10.3389/fimmu.2022.857692 |
Ejemplares similares
-
Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis
por: Komegae, Evilin Naname, et al.
Publicado: (2017) -
The Anti-Inflammatory Peptide TnP Is a Candidate Molecule for Asthma Treatment
por: Lima, Carla, et al.
Publicado: (2023) -
Early preclinical screening using zebrafish (Danio rerio) reveals the safety of the candidate anti-inflammatory therapeutic agent TnP
por: Batista-Filho, João, et al.
Publicado: (2020) -
TLR2, TLR4 and the MyD88 Signaling Are Crucial For the In Vivo Generation and the Longevity of Long-Lived Antibody-Secreting Cells
por: Komegae, Evilin Naname, et al.
Publicado: (2013) -
The Longevity of Th2 Humoral Response Induced by Proteases Natterins Requires the Participation of Long-Lasting Innate-Like B Cells and Plasma Cells in Spleen
por: Komegae, Evilin Naname, et al.
Publicado: (2013)